Skip to main content

03-06-2018 | Advanced breast cancer | Article

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3

Slamon DJ et al. J Clin Oncol 2018; JCO2018789909. doi:10.1200/JCO.2018.78.9909

Please log in to get access to this content

Related topics